Austin J. Sim, MD, JD

Early Career Representative Ex-officio

Comprehensive Cancer Center – The James Cancer Hospital, Columbus, Ohio

EDUCATION

• MD, University of Virginia School of Medicine,  2017
• JD, University of Virginia School of Law, 2017
• BA, Biochemistry and Finance, Washington University, St. Louis, 2011

POSTGRADUATE EDUCATION

• Chief Resident, Radiation Oncology, Moffitt Cancer Center, 2021 - 2022
• Resident, Radiation Oncology, Moffitt Cancer Center, 2018 - 2022
• Intern, Internal Medicine-Preliminary, Virginia Commonwealth University, 2017 - 2018

ACADEMIC APPOINTMENTS

• Assistant Professor-Clinical, Department of Radiation Oncology, James Cancer Hospital, The Ohio State University Comprehensive Cance Center, 2022 - Present

HOSPITAL APPOINTMENTS

• Acting Director of Hematologic Radiation Oncology, The Ohio State University Comprehensive Cancer Center, 2024 - Present
• The Ohio State University Faculty Council, 2022 - Present
• James Cancer Hospital, The Ohio State University Comprehensive Cancer Center/Wexner Medical Center, 2022 - Present

SERVICE TO ASTRO

• Member, Annual Meeting Education Committee Reviewers, 2024 - Present
• Member, ASTRO PAC Board, 2023 - Present
• Member, Congressional Relations Subcommittee, 2023 - Present
• Inaugural Chair, Early Career Committee, 2022 - Present
• Member, Payer Relations Committee, 2022 - Present
• Member, Workforce Subcommittee, 2021 - Present
• Member, Communication Committee, 2020 - Present
• Chair, Early Career Committee Initiative, 2022
• Member, Workforce Study Task Group, 2021 - 2023
• Member, Health Policy Committee, 2020 - 2022
• Member, Annual Meeting Scientific Committee, 2020 - 2021
• Member, Government Relations Committee, 2020 - 2021
• Chair, ARRO Executive Committee, 2021 - 2022
• Vice-chair and Founding Member, ARRO Equity and Inclusion Subcommittee, 2020 - 2021
• Chair, ARRO Communications Subcommittee, 2020 - 2021

SERVICE TO OTHER ONCOLOGY OR RADIOLOGY ORGANIZATIONS

• ABR, Initial Certification Advisory Committee, Radiation Oncology, 2022 - 2023
• ACR, TXIT Exam Writer, Hematologic Section, 2024 - Present
• ACRO, Government Relations and Economics Committee, 2019 - 2023
• ECOG, Leukemia Committee, 2024 - Present
• ILROG, Council Member, 2023 - Present
• NRG Oncology, Hematologic Malignancy Working Group, 2024 - Present
• NRG Oncology, Gastrointestinal Non-Colorectal Cancer Core Subcommittee, 2022 - Present
• NRG Oncology, Gastrointestinal Cancer Committee, 2022 - Present
• NRG Oncology, Radiation Oncology Committee, 2022 - Present
• NRG Oncology, Early Career and New Investigators Committee, 2021 - Present
• ROECSG, Graduate Medical Education Committee, 2021 - Present
• SWOG, Bone Marrow and Stem Cell Transplant Committee, 2024 - Present
• SWOG, Radiation Oncology Committee, 2023 - Present

BIOGRAPHICAL SKETCH

In the wake of the ACA, I realized even the best physicians can only do so much good if the system in which we practice is itself broken. To truly optimize care by improving the system, I became the first student to complete the joint MD/JD program at the University of Virginia. During medical school, I also discovered clinical research as another avenue to more globally optimize patient care. I completed my training at Moffitt Cancer Center, where I served as Chief Resident and as Chair of the Association of Residents in Radiation Oncology.

I have been active in multiple areas within ASTRO since early in my time as a resident, but have focused my efforts in advocacy, both in government relations/health policy, but also for trainees in radiation oncology. Since transitioning to Early Career faculty, I have shifted the latter efforts to advocate for and support Early Career practitioners within radiation oncology as the Inaugural Chair of the Early Career Committee.

I am currently an Assistant Professor in the Department of Radiation Oncology at The Ohio State University Comprehensive Cancer Center, where I serve as the Acting Director of Hematologic Radiation Oncology and Director of Medical Student Education. I serve as a Council Member in the International Lymphoma Radiation Oncology Group, as well as on multiple committees focused on radiation and hematologic malignancies within NRG Oncology, SWOG, and ECOG. My research interests are in optimizing combinations of radiotherapy with cell and other novel systemic therapies in the management of hematologic malignancies, as well as leadership and professional development.